Cargando…
Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis
Dasatinib is a tyrosine kinase inhibitor, which inhibits tumor proliferation by blocking SRC pathways and is considered as a potential treatment of various epithelial neoplasms, including pancreatic cancer. However, dasatinib efficacy is largely limited due to drug resistance. In the present study,...
Autores principales: | Wei, Jingsun, Han, Rongbo, Su, Xinyu, Chen, Yuetong, Shi, Junfeng, Cui, Xiaowen, Zhang, Honghong, Gong, Yang, Chu, Xia, Chen, Jinfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540339/ https://www.ncbi.nlm.nih.gov/pubmed/31289489 http://dx.doi.org/10.3892/ol.2019.10281 |
Ejemplares similares
-
Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients
por: Han, Rongbo, et al.
Publicado: (2018) -
Establishment and Characterization of gc-006-03, a Novel Human Signet Ring Cell Gastric Cancer Cell Line Derived from Metastatic Ascites
por: Su, Xinyu, et al.
Publicado: (2018) -
Establishment and characterization of the GC-030-35 cell line derived from gastric hepatoid adenocarcinoma
por: Wei, Jingsun, et al.
Publicado: (2019) -
Isobavachalcone sensitizes cells to E2‐induced paclitaxel resistance by down‐regulating CD44 expression in ER+ breast cancer cells
por: Shi, Junfeng, et al.
Publicado: (2018) -
The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer: A meta-analysis
por: Dai, Jiali, et al.
Publicado: (2019)